Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome

Overview of attention for article published in Molecular Cytogenetics, May 2015

Altmetric Badge

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 4 Mendeley

Summary Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms

Article in Cancer Genetics (October 2018)

Techniques for detecting chromosomal aberrations in Myelodysplastic syndromes

Article in Oncotarget (May 2017)

Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance

Article in Modern Pathology (July 2016)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.